Benoit Canolle

VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation.

Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen.

The Association for Financial Markets in Europe, also known as AFME, represents the leading banks and other significant capital market players in Europe. The British company is working with its members to make a positive contribution to the European insolvency reform debate. Adam Farkas has been the CEO of the private company since 2020.

Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

International Institute of New England, Inc. operates as a non-profit organization serving immigrants, refugees, asylees, and other vulnerable populations. Its services include refugee resettlement, case management, health services navigation, employment, education and literacy and citizenship programming. The company was founded in 1910 and is headquartered in Boston, MA.

CACEIS SAS provides banking services to the institutional and corporate clients. The firm offers fund administration, corporate trust, clearing, compliance, legal advice and reporting services. The company was founded in 2005 and is headquartered in Paris, France.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

LCH Ltd. develops and operates a clearing platform for interest rate swaps. The firm offers SwapClear, a platform that provides clearing services to the over-the-counter (OTC) interest rate swaps. It also provides risk management capabilities across a range of asset classes, including OTC and listed interest rates, fixed income, foreign exchange, credit default swap (CDS), equities, and commodities. The company was founded in 1992 and is headquartered in London, the United Kingdom.

LVMH Group is a Spanish company that sells a variety of luxury products including wines and spirits, fashion and leather goods, perfumes and cosmetics, and watches and jewelry. The private company is based in Paris, France and has subsidiaries in various countries including Ireland, Singapore, and the United States. The CEO of the company is Bernard Arnault.

The Academy of St. Martin in the Fields provides entertainment services. The private company is based in London, UK.

Unilever France SAS engages in the production and marketing of food, personal, and consumer goods. It offers pastry, desserts, pasta, food, drinks, personal care products, housekeeping items, cleaning goods, fruits, flowers, herbes, mouthwash, toothpaste, and perfumes. The company is headquartered in Rueil-Malmaison, France.

Part of Astellas Pharma, Inc., Astellas BV is a Dutch company that functions as an investment holding company. The company is based in Leiden, Netherlands.

Khondrion BV is a Dutch clinical-stage biopharmaceutical company that focuses on discovering and developing therapies for mitochondrial diseases. The company is based in Nijmegen, Netherlands, and was founded in 2012 by Jan Smeitink, who has been the CEO since then. The company's lead drug candidate, sonlicromanol, is a first-in-class, oral small molecule that targets key underlying mechanisms of primary mitochondrial disease. The compound has been granted orphan drug designations for the treatment of various mitochondrial diseases. Khondrion collaborates with a clinical and academic network and patient organizations internationally to accelerate the discovery and development of its potential medicines.

Part of Biophytis SA, Biophytis, Inc. operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes. The company is based in Newark, DE.

Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ.

Humanim, Inc. provides human services and workforce development resources. Its services include mental health, vocational, neuro-rehabilitation, developmental disabilities and deaf services. The company was founded in 1971 and is headquartered in Columbia, MD.

Bionest Partners, Inc. provides consulting services to the medical industry. The firm offers expertise in all aspects of the life sciences including medical devices, diagnostics, research and development, marketing, corporate development, and personal medicine strategy. The company was founded by Robert J. Easton in 2003 and is headquartered in New York, NY.

Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France.

Exane SA (Broker) (Exane) is the brokerage division of Exane SA, itself a subsidiary of Verner Investissements SAS in France. Established in 2004 as a joint venture between BNP Paribas and Verner Investissements, the firm is based in Paris and specializes in European equity research and broking activities. Exane has research centers in Paris and London which are supported by a team of economists and strategists.

CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France.

Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million.